EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
2.7.1.140 | ATP + myo-inositol 1,3,4,5-tetrakisphosphate |
approx. 2% of activity with 1,3,4,6-tetrakisphosphate |
Homo sapiens |
ADP + myo-inositol-1,3,4,5,6-pentakisphosphate |
- |
? |
2.7.1.140 | ATP + myo-inositol 1,3,4,6-tetrakisphosphate |
- |
Homo sapiens |
ADP + myo-inositol 1,3,4,5,6-pentakisphosphate |
- |
? |
2.7.1.140 | ATP + myo-inositol 1,3,4,6-tetrakisphosphate |
- |
Rattus norvegicus |
ADP + myo-inositol 1,3,4,5,6-pentakisphosphate |
- |
? |
2.7.1.140 | ATP + myo-inositol 1,3,4,6-tetrakisphosphate |
- |
Bos taurus |
ADP + myo-inositol 1,3,4,5,6-pentakisphosphate |
- |
? |
2.7.1.140 | ATP + myo-inositol 1,3,4,6-tetrakisphosphate |
involved in synthesis of higher phosphorylated inositol phosphates |
Rattus norvegicus |
ADP + myo-inositol 1,3,4,5,6-pentakisphosphate |
- |
? |
2.7.1.140 | ATP + myo-inositol 1,3,4,6-tetrakisphosphate |
- |
Rattus norvegicus Sprague-Dawley |
ADP + myo-inositol 1,3,4,5,6-pentakisphosphate |
- |
? |
2.7.1.140 | ATP + myo-inositol 1,3,4,6-tetrakisphosphate |
involved in synthesis of higher phosphorylated inositol phosphates |
Rattus norvegicus Sprague-Dawley |
ADP + myo-inositol 1,3,4,5,6-pentakisphosphate |
- |
? |
2.7.1.140 | ATP + myo-inositol 1,4,5-trisphosphate |
approx. 50% of activity with 1D-myo-inositol 1,3,4,6-tetrakisphosphate, no activity with 1D-myo-inositol 1,3,4-trisphosphate |
Homo sapiens |
ADP + myo-inositol-1,3,4,5-tetrakisphosphate |
- |
? |